Cargando…
Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes
Type 2 diabetes mellitus (T2DM) is a chronic metabolic abnormality leading to microvascular and macrovascular complications. Non-insulin Incretin mimic synthetic peptide exendin-4 was introduced as an anti-diabetic drug which helped diabetic patients with triggering insulin secretion; further resear...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tabriz University of Medical Sciences
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106955/ https://www.ncbi.nlm.nih.gov/pubmed/35620334 http://dx.doi.org/10.34172/apb.2022.025 |